student assistance

UFMG receives 'seed virus' to develop Brazilian vaccine against monkeypox

UFMG receives ‘seed virus’ to develop Brazilian vaccine against monkeypox

Marcelo Morales, from MCTI, and Flávio Fonseca, from CTVacinas, received the biological material that will serve as a basis for testing the vaccine against monkeypox Raphaella Dias | UFMG A vaccine similar to Jynneos/Imvanex, an immunizer from the Bavarian Nordic A/S company used for the prevention of monkeypox, will soon begin to be produced in …

UFMG receives ‘seed virus’ to develop Brazilian vaccine against monkeypox Read More »

CTVacinas advances another step in the development of SpiN-TEC

CTVacinas advances another step in the development of SpiN-TEC

Researcher at CTVacinas, which develops research into immunizing agents for various diseases Foca Lisbon | UFMG Brazil is getting closer and closer to having the first 100% national human vaccine. This is SpiN-TEC, an immunizing agent against covid-19 developed by CTVacinas of UFMG in partnership with the Oswaldo Cruz Foundation (Fiocruz MG). The article Promotion …

CTVacinas advances another step in the development of SpiN-TEC Read More »